Resistance to Targeted Therapies in Lymphomas
This volume will review different classes of "target" drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but also help...
Συγγραφή απο Οργανισμό/Αρχή: | SpringerLink (Online service) |
---|---|
Άλλοι συγγραφείς: | Xavier, Ana C. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Cairo, Mitchell S. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt) |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
Έκδοση: | 1st ed. 2019. |
Σειρά: | Resistance to Targeted Anti-Cancer Therapeutics,
21 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Παρόμοια τεκμήρια
-
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
Έκδοση: (2018) -
Resistance to Ibritumomab in Lymphoma
Έκδοση: (2018) -
Current Applications for Overcoming Resistance to Targeted Therapies
Έκδοση: (2019) -
Cancer Stem Cell Resistance to Targeted Therapy
Έκδοση: (2019) -
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
Έκδοση: (2018)